5//SEC Filing
Laskow-Pooley David 5
Accession 0001209191-21-010231
CIK 0001094038other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:13 PM ET
Size
5.3 KB
Accession
0001209191-21-010231
Insider Transaction Report
Form 5
Laskow-Pooley David
Director
Transactions
- Award
Common Stock
2020-05-19+17,022→ 42,565 total
Footnotes (1)
- [F1]Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $2.35 per share, on the day immediately preceding the date of the Company's 2019 annual meeting.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001638533
Filing Metadata
- Form type
- 5
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:13 PM ET
- Size
- 5.3 KB